[1]

YAN Xiao-lin, PENG Jun, DING Qi-long. Nongenomic actions of thyroid hormone and the cardiovascular function [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 586-591.

[2]

SUN Ai-jing, XU Xian-xiang, XU Rui-an. Anti-inflammatory mechanism of estrogens [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1072-1076.

[3]

WANG Mei-mei, ZHU Xiao-xia, SUN Ru-rong, XU Lei-ting. Inhibition effects of methylprednisolone on over-expression of transforming growth factor-β₁ (TGF-β₁) in kidneys of BXSB mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(7): 799-803.

[4]

CHEN Lu-ying, XU Jiang-ping, PANG Jian-xin, SHI Dao-hua. Antiproliferative effects of pioglitazone involved of nitric oxide on cultured rabbit aortic smooth muscle cells [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 642-645.

[5]

LIN Yi-ping, LI Chang-chong, HU Ye, LI Men-grong, Chen Xiao-fang, MAO Yu-fei. Effects of budesonide on signal pathway of IKK /NF-κB in asthma rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 691-696.

[6]

LI Hong-hui, LIU En-bo, XIE Qun, DING Su-jie, HE Tao, LI Jia-fu. Influence of rosiglitazone and metformin on blood pressure in treatment of patients with type 2 diabetes mellitus [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 717-720.

[7]

YE Jin-yan, XIE Yu-peng, MAO Sun-zhong, FANG Zhou-xi, CHEN Shao-xian. Effects of dexameathone on pulmonary fibrosis induced by bleomycin and oxygen-derived free radicals in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 397-400.

[8]

ZHANG Shao-ying, PING Jie, WANG Hui. Influence of estrogen on metabolism and antioxidative functions in old cas-trated female rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 424-427.

[9]

ZHANG Peng, LI Hong-fang, TIAN Zhi-feng, QIU Xiao-qing, ZHANG Ying-fu. Effects of genistein and estradiol on ROS-mediated vasoconstriction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 87-90.

[10]

ZHENG Lin-ying, PAN Jing-qiang, LIN Jie-ru, XIAO Liu-ying, LI Bo-ping, HAN Chao. Effects and mechanisms of rosiglitazone on insulin resistance in rats with hyperlipemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 96-99.

[11]

FU Li-Juan, WANG Hong-Xin, PANG Dong-Bo, BAO Cui-Fen. Research of nonenzymation glyscation inhibitor on cardiac myocyte apoptosis in diabetic rats with heart failure [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(12): 1374-1376.

[12]

ZHANG Ya-Li, XIAO Mei-Fang, TAN Huan-Ran. Research on primary culture model of pancreatic islets in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(11): 1231-1235.

[13]

ZHOU Yong-An, LIU Kun, ZHANG Tao, GU Zhong-Ping. Protective effects of prostaglandin E₁ on ischemia/reperfusion-induced lung injury after lung transplantation in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(11): 1278-1280.

[14]

[15]

WANG Rui, ZHOU Xiao-Qing, DONG Jun, WEI Rong, CAO Xiu-Tang, ZHOU Ya-Chun, WANG Jin, GUO Dai-Hong, CHEN Kun, ZHOU Jian, WANG Jie-Song, ZHU Xiu-Mei, LIANG Bei-Bei, XU Yan-Ping, ZHOU Xian-Zhi. Effects and adverse drug reactions of mtrisone in the treatment of patients with severe acute respiratory syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 992-996.

PDF (PC)

Knowledge